Cargando…
Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson’s Disease
Neuroinflammation and oxidative stress underlie the pathogenesis of various neurodegenerative disorders. Here we demonstrate that sodium phenylbutyrate (NaPB), an FDA-approved therapy for reducing plasma ammonia and glutamine in urea cycle disorders, can suppress both proinflammatory molecules and r...
Autores principales: | Roy, Avik, Ghosh, Anamitra, Jana, Arundhati, Liu, Xiaojuan, Brahmachari, Saurav, Gendelman, Howard E., Pahan, Kalipada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377667/ https://www.ncbi.nlm.nih.gov/pubmed/22723850 http://dx.doi.org/10.1371/journal.pone.0038113 |
Ejemplares similares
-
Upregulation of DJ-1 in Dopaminergic Neurons by a Physically-Modified Saline: Implications for Parkinson’s Disease
por: Jana, Malabendu, et al.
Publicado: (2023) -
Cinnamon and Its Metabolite Sodium Benzoate Attenuate the Activation of p21(rac) and Protect Memory and Learning in an Animal Model of Alzheimer’s Disease
por: Modi, Khushbu K., et al.
Publicado: (2015) -
Myelin Basic Protein-primed T Helper 2 Cells Suppress Microglial Activation via AlphaVBeta3 Integrin: Implications for Multiple Sclerosis
por: Roy, Avik, et al.
Publicado: (2013) -
BPOZ-2 Gene Delivery Ameliorates Alpha-Synucleinopathy in A53T Transgenic Mouse Model of Parkinson’s Disease
por: Roy, Avik, et al.
Publicado: (2016) -
Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer’s disease mouse model
por: Chandra, Sujyoti, et al.
Publicado: (2018)